A Retrospective Real-World Study of the Effectiveness and Tolerability of Tildrakizumab in UK Adults with Moderate-to-Severe Chronic Plaque Psoriasis

INTRODUCTION: As with most medicines historically, clinicians prescribing tildrakizumab have relied on information derived from registration studies undertaken in a prospective controlled clinical trial setting. More recently, clinicians, policymakers, and commissioners increasingly rely on real-wor...

Descripción completa

Detalles Bibliográficos
Autores principales: Becher, Gabrielle, Conner, Sophia, Ingram, Jennifer A., Stephen, Karen E., McInnes, Alison C., Heald, Adrian H., Riley, Paul A., Davies, Mark, Domenech, Arnau, Kasujee, Ismail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458480/
https://www.ncbi.nlm.nih.gov/pubmed/36076145
http://dx.doi.org/10.1007/s13555-022-00800-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458480/
https://www.ncbi.nlm.nih.gov/pubmed/36076145
http://dx.doi.org/10.1007/s13555-022-00800-3

Ejemplares similares